Summary
- Current Price
- As of today, NVAX price is $10.11, up +9.78% in the most recent trading session on
- Current Price All-Time High
- NVAX price is currently -96.95% below its historical high of $331.68 set on
- Market Cap
- NVAX current market cap is $2B, up +41.59% over the past 365 days
- PE Ratio
- NVAX PE ratio is unknown
- Revenue
- NVAX current annual revenue is $1.12B, up +64.69% year-over-year
- Next Earnings
- The next earnings release for NVAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Novavax, Inc. |
| Ticker | NASDAQ: NVAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | novavax.com |
| Employees | 952 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $10.11 | |
| Price, 1D Change | +9.78% | |
| $2B | ||
| - | ||
| - | ||
| 2.16 | ||
| $1B | ||
| Revenue, 1Y Change | +64.69% | |
| $2.54 | ||
| EPS, 1Y Change | +306.46% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.54 | ||
| EPS Estimate | N/A | -$0.47 |
| EPS Est. Change | N/A | -118.60% |
| $1.12B | ||
| Revenue Estimate | N/A | $409.97M |
| Revenue Est. Change | N/A | -63.51% |
| Current Price | $10.11 | |
| Price Target | - | $16.02 |
| Price Tgt. Change | - | +58.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.33 | -$1.23 | +7.69% | |
| $2.15 | $2.54 | +18.38% | |
| -$0.47 | N/A | -118.60% | |
| -$0.25 | N/A | -110.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $684.95M | $682.16M | -0.41% | |
| $1.06B | $1.12B | +5.73% | |
| $409.97M | N/A | -63.51% | |
| $258.47M | N/A | -76.99% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $10.11 | |
| $8.35 | ||
| SMA 200 vs Price | -17.45% | |
| $8.81 | ||
| SMA 50 vs Price | -12.87% | |
| 2.16 | ||
| $0.55 | ||
| 54.33 | ||
| 51.23% | ||
| 66.52% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.12B | ||
| $2.54 | ||
| $0.00 | ||
| 93.67% | ||
| $563.27M | ||
| 50.14% | ||
| $440.30M | ||
| 39.19% | ||
| $590.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.18 | ||
| 2.13 | ||
| 2.10 | ||
| - | ||
| 1 | ||
| -3.17 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.79 | ||
| -11.49 | ||
| 19.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$127.75M | ||
| $745.96M | ||
| $1.18B | ||
| $978.28M | ||
| $1.31B | ||
| $459.95M | ||
| $278.05M | ||
| $12.39M | ||
| $24.58M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $683.18M | ||
| $489.07M | ||
| $71.14M | ||
| $157.48M | ||
| $27.61M | ||
| $0.00 | ||
| $1.87M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$244.64M | ||
| -$78.27M | ||
| $27.74M | ||
| $6.39M | ||
| -$251.02M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| JP Morgan | → | |
| B. Riley Securities | → | |
| TD Cowen | → | |
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with NVAX
FAQ
What is the ticker symbol for Novavax, Inc.?
The ticker symbol for Novavax, Inc. is NASDAQ:NVAX
Does Novavax, Inc. pay dividends?
No, Novavax, Inc. does not pay dividends
What sector is Novavax, Inc. in?
Novavax, Inc. is in the Healthcare sector
What industry is Novavax, Inc. in?
Novavax, Inc. is in the Biotechnology industry
What country is Novavax, Inc. based in?
Novavax, Inc. is headquartered in United States
When did Novavax, Inc. go public?
Novavax, Inc. initial public offering (IPO) was on December 5, 1995
Is Novavax, Inc. in the S&P 500?
No, Novavax, Inc. is not included in the S&P 500 index
Is Novavax, Inc. in the NASDAQ 100?
No, Novavax, Inc. is not included in the NASDAQ 100 index
Is Novavax, Inc. in the Dow Jones?
No, Novavax, Inc. is not included in the Dow Jones index
When was Novavax, Inc. last earnings report?
Novavax, Inc.'s most recent earnings report was on May 6, 2026
When does Novavax, Inc. report earnings?
The next expected earnings date for Novavax, Inc. is August 5, 2026
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069426000007/0001000694-26-000007-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax